Impact of Achieving ASDAS LDA on Disease Activity and Patient-Reported Outcome Measures Among Patients with Ankylosing Spondylitis Treated with Biologic DMARDs - ACR Meeting Abstracts
Por um escritor misterioso
Descrição
Background/Purpose: Although Ankylosing Spondylitis Disease Activity Score (ASDAS) low disease activity (LDA) is a common treatment target for disease control when managing AS, real-world research describing ASDAS LDA achievement among patients treated with biologic DMARDs (bDMARD) is limited. The aim of this study was to describe disease activity and patient-reported outcome measures (PROMs) among patients […]
Canadian Rheumatology Association Meeting Quebec City Convention
PDF) Impact of Secukinumab on Patient-Reported Outcomes in the
Measures of symptoms and disease status in ankylosing spondylitis
PDF) Golimumab as the First-, Second-, or at Least Third-Line
PDF) Response to lower dose TNF inhibitors in axial
PDF) Achieving minimal disease activity in psoriatic arthritis
Dose reduction and withdrawal strategy for TNF-inhibitors in
Frontiers Residual Pain in the Context of Selecting and
Safety Profile, Axial Spondyloarthritis
Disease Activity-Guided Stepwise Tapering but Not Discontinuation
de
por adulto (o preço varia de acordo com o tamanho do grupo)
